• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应激激酶在肝脂肪变性和肝细胞癌发展中的作用。

Stress kinases in the development of liver steatosis and hepatocellular carcinoma.

机构信息

Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.

Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.

出版信息

Mol Metab. 2021 Aug;50:101190. doi: 10.1016/j.molmet.2021.101190. Epub 2021 Feb 13.

DOI:10.1016/j.molmet.2021.101190
PMID:33588102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8324677/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is an important component of metabolic syndrome and one of the most prevalent liver diseases worldwide. This disorder is closely linked to hepatic insulin resistance, lipotoxicity, and inflammation. Although the mechanisms that cause steatosis and chronic liver injury in NAFLD remain unclear, a key component of this process is the activation of stress-activated kinases (SAPKs), including p38 and JNK in the liver and immune system. This review summarizes findings which indicate that the dysregulation of stress kinases plays a fundamental role in the development of steatosis and are important players in inducing liver fibrosis. To avoid the development of steatohepatitis and liver cancer, SAPK activity must be tightly regulated not only in the hepatocytes but also in other tissues, including cells of the immune system. Possible cellular mechanisms of SAPK actions are discussed.

摘要

非酒精性脂肪性肝病 (NAFLD) 是代谢综合征的一个重要组成部分,也是全球最常见的肝脏疾病之一。这种疾病与肝胰岛素抵抗、脂毒性和炎症密切相关。虽然导致 NAFLD 中脂肪变性和慢性肝损伤的机制尚不清楚,但该过程的一个关键组成部分是应激激活激酶 (SAPKs) 的激活,包括肝脏和免疫系统中的 p38 和 JNK。本综述总结了一些发现,这些发现表明应激激酶的失调在脂肪变性的发展中起着根本性的作用,并且是诱导肝纤维化的重要因素。为了避免脂肪性肝炎和肝癌的发展,SAPK 活性不仅必须在肝细胞中而且还必须在其他组织中受到严格调节,包括免疫系统的细胞。讨论了 SAPK 作用的可能细胞机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/c055e6f895fd/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/2f41ab98411b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/e13beb81aa78/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/73cee632642e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/e58cf2854ba5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/c055e6f895fd/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/2f41ab98411b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/e13beb81aa78/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/73cee632642e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/e58cf2854ba5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b7/8324677/c055e6f895fd/gr5.jpg

相似文献

1
Stress kinases in the development of liver steatosis and hepatocellular carcinoma.应激激酶在肝脂肪变性和肝细胞癌发展中的作用。
Mol Metab. 2021 Aug;50:101190. doi: 10.1016/j.molmet.2021.101190. Epub 2021 Feb 13.
2
Autophagy, NAFLD and NAFLD-Related HCC.自噬、非酒精性脂肪性肝病和非酒精性脂肪性肝病相关的肝细胞癌。
Adv Exp Med Biol. 2018;1061:127-138. doi: 10.1007/978-981-10-8684-7_10.
3
Apoptosis and non-alcoholic fatty liver diseases.细胞凋亡与非酒精性脂肪性肝病。
World J Gastroenterol. 2018 Jul 7;24(25):2661-2672. doi: 10.3748/wjg.v24.i25.2661.
4
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的脂质组学生物标志物和脂毒性机制。
Free Radic Biol Med. 2019 Nov 20;144:293-309. doi: 10.1016/j.freeradbiomed.2019.05.029. Epub 2019 May 29.
5
Hepatoprotective Effect of Loquat Leaf Flavonoids in PM-Induced Non-Alcoholic Fatty Liver Disease via Regulation of IRs-1/Akt and CYP2E1/JNK Pathways.枇杷叶黄酮通过调节 IRS-1/Akt 和 CYP2E1/JNK 通路对 PM 诱导的非酒精性脂肪肝病的保护作用。
Int J Mol Sci. 2018 Oct 1;19(10):3005. doi: 10.3390/ijms19103005.
6
Deranged hepatocyte intracellular Ca homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma.肝细胞内 Ca 稳态紊乱与非酒精性脂肪性肝病向肝细胞癌的进展。
Cell Calcium. 2019 Sep;82:102057. doi: 10.1016/j.ceca.2019.102057. Epub 2019 Jul 26.
7
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
8
Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.过氧化物酶体 β-氧化调节全身代谢、炎症活力和非酒精性脂肪性肝病的发病机制。
JCI Insight. 2018 Mar 22;3(6):93626. doi: 10.1172/jci.insight.93626.
9
Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.丰加霉素可减轻游离脂肪酸诱导的培养肝细胞中的肝脂肪变性和细胞凋亡,并改善小鼠的非酒精性脂肪性肝病。
PLoS One. 2017 Mar 9;12(3):e0170591. doi: 10.1371/journal.pone.0170591. eCollection 2017.
10
Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.乳铁蛋白通过Akt信号通路减轻脂肪酸诱导的肝癌细胞脂毒性。
Biochem Cell Biol. 2015 Dec;93(6):566-73. doi: 10.1139/bcb-2015-0014. Epub 2015 Jul 28.

引用本文的文献

1
Adipocyte-specific deletion of gp130 prevents ketogenic diet-induced hepatic steatosis.脂肪细胞特异性缺失gp130可预防生酮饮食诱导的肝脂肪变性。
Hepatol Commun. 2025 Aug 26;9(9). doi: 10.1097/HC9.0000000000000782. eCollection 2025 Sep 1.
2
p38α MAPK Regulation of Energy Metabolism in Skeletal Muscle Offers a Therapeutic Path for Type 2 Diabetes.p38α丝裂原活化蛋白激酶对骨骼肌能量代谢的调节为2型糖尿病提供了一条治疗途径。
Cells. 2025 Aug 18;14(16):1277. doi: 10.3390/cells14161277.
3
Therapeutic Potential of STE20-Type Kinase STK25 Inhibition for the Prevention and Treatment of Metabolically Induced Hepatocellular Carcinoma.

本文引用的文献

1
Neutrophil infiltration regulates clock-gene expression to organize daily hepatic metabolism.中性粒细胞浸润调节时钟基因表达以组织肝脏的日常代谢。
Elife. 2020 Dec 8;9:e59258. doi: 10.7554/eLife.59258.
2
TGF‑β1‑induced autophagy activates hepatic stellate cells via the ERK and JNK signaling pathways.TGF-β1 诱导的自噬通过 ERK 和 JNK 信号通路激活肝星状细胞。
Int J Mol Med. 2021 Jan;47(1):256-266. doi: 10.3892/ijmm.2020.4778. Epub 2020 Nov 3.
3
Brain JNK and metabolic disease.脑 JNK 与代谢疾病。
STE20型激酶STK25抑制在预防和治疗代谢性诱导肝细胞癌中的治疗潜力
Cell Mol Gastroenterol Hepatol. 2025 Feb 28;19(7):101485. doi: 10.1016/j.jcmgh.2025.101485.
4
PreS1 deletions in genotype C HBV leads to severe hepatic inflammation and hepatocarcinogenesis via the IRE1-JNK axis.C基因型乙肝病毒前S1缺失通过IRE1-JNK轴导致严重的肝脏炎症和肝癌发生。
JHEP Rep. 2024 Nov 15;7(3):101274. doi: 10.1016/j.jhepr.2024.101274. eCollection 2025 Mar.
5
Modulation of gut microbiota in targeted cancer therapy: insights on the EGFR/VEGF/KRAS pathways.靶向癌症治疗中肠道微生物群的调节:对表皮生长因子受体/血管内皮生长因子/ Kirsten 大鼠肉瘤病毒癌基因同源物途径的见解
Cancer Biol Med. 2024 Nov 25;21(12):1141-55. doi: 10.20892/j.issn.2095-3941.2024.0320.
6
Microcystin-LR activates serine/threonine kinases and alters the phosphoproteome in human HepaRG cells.微囊藻毒素-LR 激活丝氨酸/苏氨酸激酶并改变人 HepaRG 细胞的磷酸化蛋白质组。
Toxicon. 2024 Oct;249:108072. doi: 10.1016/j.toxicon.2024.108072. Epub 2024 Aug 20.
7
Gossypetin targets the liver-brain axis to alleviate pre-existing liver fibrosis and hippocampal neuroinflammation in mice.棉黄素作用于肝脑轴以减轻小鼠已有的肝纤维化和海马神经炎症。
Front Pharmacol. 2024 May 27;15:1385330. doi: 10.3389/fphar.2024.1385330. eCollection 2024.
8
Stress-Activated Protein Kinases in Intervertebral Disc Degeneration: Unraveling the Impact of JNK and p38 MAPK.椎间盘退变中的应激激活蛋白激酶:揭示JNK和p38丝裂原活化蛋白激酶的影响
Biomolecules. 2024 Mar 25;14(4):393. doi: 10.3390/biom14040393.
9
Macrophage metabolism in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的巨噬细胞代谢。
Front Immunol. 2023 Oct 4;14:1257596. doi: 10.3389/fimmu.2023.1257596. eCollection 2023.
10
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.JNKs通过调节Apelin信号通路来保护机体免受胆汁淤积性肝病进展的影响。
JHEP Rep. 2023 Jul 18;5(11):100854. doi: 10.1016/j.jhepr.2023.100854. eCollection 2023 Nov.
Diabetologia. 2021 Feb;64(2):265-274. doi: 10.1007/s00125-020-05327-w. Epub 2020 Nov 16.
4
β-Arrestin2 deficiency attenuates oxidative stress in mouse hepatic fibrosis through modulation of NOX4.β-arrestin2 缺乏通过调节 NOX4 减轻小鼠肝纤维化中的氧化应激。
Acta Pharmacol Sin. 2021 Jul;42(7):1090-1100. doi: 10.1038/s41401-020-00545-9. Epub 2020 Oct 28.
5
The role of stress kinases in metabolic disease.应激激酶在代谢性疾病中的作用。
Nat Rev Endocrinol. 2020 Dec;16(12):697-716. doi: 10.1038/s41574-020-00418-5. Epub 2020 Oct 16.
6
p38 MAPK Pathway in the Heart: New Insights in Health and Disease.心脏中的p38丝裂原活化蛋白激酶信号通路:健康与疾病的新见解
Int J Mol Sci. 2020 Oct 8;21(19):7412. doi: 10.3390/ijms21197412.
7
Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture.人微小 RNA,miR-6133-5p,对培养的肝星状细胞纤维化活性的抑制作用。
Int J Mol Sci. 2020 Oct 1;21(19):7251. doi: 10.3390/ijms21197251.
8
Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice.靶向卵泡抑素样蛋白 1 通过 TGF-β1-miR29a 减轻四氯化碳诱导的肝纤维化。
Cell Commun Signal. 2020 Sep 15;18(1):151. doi: 10.1186/s12964-020-00610-0.
9
High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis.高脂肪饮食可诱导缺乏 CYP2A5 和 PPARα 的小鼠发生纤维化:一种与脂肪性肝炎相关纤维化相关的新型模型。
Am J Physiol Gastrointest Liver Physiol. 2020 Nov 1;319(5):G626-G635. doi: 10.1152/ajpgi.00213.2020. Epub 2020 Sep 2.
10
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation.微生物咪唑丙酸通过 p38γ 依赖性抑制 AMPK 磷酸化影响二甲双胍的反应。
Cell Metab. 2020 Oct 6;32(4):643-653.e4. doi: 10.1016/j.cmet.2020.07.012. Epub 2020 Aug 11.